Evidence map›Paper›PMID 41695216›Full record

ArticleKidney medicine2026

An Exceptional Case of Crohn-Associated IgA-Mediated Goodpasture Disease.

Rebecca Ryan, Thomas Fairhead, Sophie Seager, Mona Jain, Rauri Clark

Abstract readCase Reports
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rebecca RyanNephrology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
Thomas FairheadInternal Medicine, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
Sophie SeagerInternal Medicine, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
Mona JainPathology, Gateshead Health NHS Foundation Trust, Gateshead, Tyne and Wear, UK.
Rauri ClarkNephrology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-glomerular basement membrane (anti-GBM) disease is typically mediated by IgG autoantibodies and presents with pulmonary hemorrhage and rapidly progressive glomerulonephritis, classically referred to as Goodpasture disease. We describe a novel IgA-mediated variant in a 53-year-old man with Crohn colitis, who presented with oligo-anuric acute kidney injury and hemoptysis. Despite having negative serology for anti-GBM antibodies, kidney biopsy revealed necrotizing crescentic glomerulonephritis with linear IgA deposition along the glomerular basement membrane. We suspect that a Crohn colitis flare may have incited a novel IgA-driven anti-GBM process which, remarkably, resolved in the absence of conventional immunosuppressive therapy, sharply deviating from previously reported IgA-mediated disease requiring aggressive intervention. Such a case suggests a possible link between abnormal IgA glycosylation in inflammatory bowel disease and the development of a unique IgA-mediated anti-GBM process. Recognition of this entity may broaden the diagnostic approach to seronegative pulmonary-renal syndromes and also highlight the potential for nonimmunosuppressive management.

Indexed as

acute kidney injuryanti-GBManti-glomerular basement membrane diseaseAntiglomerular basement membrane diseasecrescentic glomerulonephritisCrohn diseaseGoodpasture syndromeIgA-mediated anti-GBM diseaseimmunofluorescenceimmunoglobulin Ainflammatory bowel diseasekidney biopsylinear IgA depositionpulmonary hemorrhagepulmonary-renal syndromerapidly progressive glomerulonephritisseronegative anti-GBM disease

Identifiers

PMID41695216
PMCPMC12905745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.